Seventh-Day Adventists Loma Linda University Medical Center

Seventh-Day Adventists Loma Linda University Medical Center was paid $253.66M by Medicaid between Jan 2018 and Nov 2024, across 682 billing codes. Its largest line is 0450, Emergency room services — 26% of everything it billed.

33Billing provider infoSEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER
LOMA LINDA, CA 92354

33aNPI1912914821assigned 08/02/2006

33bProvider typeRehabilitation Hospital Unit

28Total paid$253.66M

24GClaims3,899,170

24DCodes billed682

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Rehabilitation Hospital Unit providers in California

Rank by total paid#1 of 22

Median peer was paid$308K

This provider vs. median823×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	459,265	$26.14M
2019	500,317	$32.78M
2020	485,252	$30.61M
2021	572,421	$36.35M
2022	577,582	$37.28M
2023	672,518	$46.05M
2024incomplete	631,815	$44.45M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	26%	105,812	94,396	$64.90M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	14%	50,654	45,688	$36.16M
L8699	Prosthetic implant, not otherwise specified	4.6%	4,377	2,760	$11.70M
J9271	Injection, pembrolizumab, 1 mg	4.3%	3,887	1,373	$10.96M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	2.1%	8,224	8,084	$5.31M
78815	Positron emission tomography (PET) for limited area imaging	2.0%	2,886	2,863	$4.97M
S5102	Adult day care, billed per dayDay care services, adult; per diem	1.8%	55,320	3,311	$4.45M
90999	Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient	1.6%	30,338	2,292	$4.01M
0360		1.4%	28,764	12,986	$3.62M
J9312	Injection, rituximab, 10 mg	1.3%	2,470	1,080	$3.40M
J3490	Unclassified drugs	1.2%	221,940	87,612	$2.92M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.0%	13,758	13,207	$2.65M

670 more codes

96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	20,247	$2.37M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	66,392	$2.26M
J2505	Injection, pegfilgrastim, 6 mg	<1%	1,287	$2.18M
77523		<1%	1,616	$2.14M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	13,045	$2.07M
J9035	Injection, bevacizumab, 10 mg	<1%	1,302	$1.98M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	86,501	$1.95M
99284	Emergency room visit (serious)	<1%	7,509	$1.93M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	19,716	$1.93M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	1,045	$1.93M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	1,656	$1.88M
99221		<1%	10,986	$1.81M
J7050	Infusion, normal saline solution, 250 cc	<1%	96,536	$1.58M
J9299	Injection, nivolumab, 1 mg	<1%	818	$1.52M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	18,036	$1.50M
99285	Emergency room visit (most serious)	<1%	3,592	$1.41M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	4,547	$1.38M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,965	$1.35M
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	1,705	$1.28M
96375	Therapeutic injection; each additional sequential IV push	<1%	41,357	$1.17M
95782		<1%	1,100	$1.05M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	39,895	$997K
99070		<1%	297,203	$979K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	15,299	$951K
80053	Comprehensive metabolic panel	<1%	145,831	$941K
0710		<1%	23,804	$936K
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	<1%	17,960	$899K
95713		<1%	1,082	$888K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,819	$815K
77334		<1%	2,891	$810K
70450	Computed tomography, head or brain; without contrast material	<1%	15,794	$769K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	6,033	$760K
J0897	Injection, denosumab, 1 mg	<1%	1,122	$736K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	35,006	$708K
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	<1%	1,498	$707K
95811		<1%	2,388	$681K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	36,819	$655K
74183		<1%	2,051	$621K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	699	$615K
J2704	Injection, propofol, 10 mg	<1%	36,147	$612K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	13,336	$610K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	27,742	$610K
77300		<1%	1,775	$600K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,115	$594K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,919	$588K
90945		<1%	11,226	$587K
0456		<1%	21,011	$586K
97750		<1%	12,049	$583K
77417		<1%	13,747	$565K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	3,765	$538K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	44,537	$535K
0510		<1%	14,272	$515K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,400	$507K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	10,628	$505K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,635	$489K
72141		<1%	1,393	$488K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	114,102	$484K
71250		<1%	3,710	$478K
71046	Radiologic examination, chest; 2 views	<1%	38,330	$476K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	44,541	$475K
96415		<1%	8,474	$461K
77295		<1%	756	$450K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	6,948	$447K
0516		<1%	13,777	$446K
99238	Hospital discharge day management, 30 minutes or less	<1%	13,423	$440K
72197		<1%	1,495	$427K
96417		<1%	6,141	$417K
93325		<1%	4,851	$399K
95700		<1%	1,327	$390K
54161		<1%	2,361	$389K
86923		<1%	4,894	$383K
77336		<1%	5,348	$369K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	25,239	$360K
72156		<1%	571	$354K
97799		<1%	13,857	$331K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,136	$326K
77412		<1%	4,990	$323K
77290		<1%	2,101	$322K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	43,299	$310K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,682	$304K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	12,556	$301K
95806		<1%	2,276	$300K
85027		<1%	59,218	$293K
96361	Intravenous infusion, hydration; each additional hour	<1%	20,738	$293K
93976		<1%	5,148	$291K
70491		<1%	1,963	$284K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	7,569	$283K
J0185	Injection, aprepitant, 1 mg	<1%	3,512	$282K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,118	$278K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	24,528	$275K
0750		<1%	3,390	$268K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,887	$267K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,058	$266K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	14,937	$260K
86922		<1%	369	$259K
99218		<1%	1,444	$257K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,258	$255K
71275	Computed tomographic angiography, chest, with contrast material	<1%	4,043	$253K
99232	Hospital visit by a doctor, follow-up day	<1%	3,880	$250K
V2632	Posterior chamber intraocular lens	<1%	1,375	$249K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,870	$244K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	379	$244K
93351		<1%	1,928	$237K
88341		<1%	1,574	$237K
93975		<1%	3,427	$234K
76830	Ultrasound, transvaginal	<1%	6,250	$232K
97763		<1%	6,555	$231K
J0690	Injection, cefazolin sodium, 500 mg	<1%	15,415	$231K
72158		<1%	350	$230K
70496		<1%	2,442	$227K
93320		<1%	4,188	$227K
J2350	Injection, ocrelizumab, 1 mg	<1%	13	$225K
0370		<1%	3,049	$221K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	11,912	$214K
70498		<1%	2,866	$210K
J9310	Injection, rituximab, 100 mg	<1%	187	$206K
80048	Basic metabolic panel (calcium, ionized)	<1%	26,889	$205K
93970		<1%	2,674	$205K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,444	$203K
76770		<1%	4,394	$203K
93247		<1%	1,882	$202K
70543		<1%	770	$197K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,880	$197K
97139		<1%	8,742	$194K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	1,116	$193K
J1170	Injection, hydromorphone, up to 4 mg	<1%	12,171	$191K
49083		<1%	1,972	$189K
J0485	Injection, belatacept, 1 mg	<1%	991	$188K
J9306	Injection, pertuzumab, 1 mg	<1%	291	$186K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	28,338	$185K
70486		<1%	2,765	$183K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,536	$183K
71045	Radiologic examination, chest; single view	<1%	20,020	$182K
72125	Computed tomography, cervical spine; without contrast material	<1%	5,358	$173K
95819		<1%	1,776	$171K
93971		<1%	4,092	$157K
84703		<1%	46,833	$155K
A4657	Syringe, with or without needle, each	<1%	6,371	$155K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,790	$154K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	13,358	$153K
82962		<1%	41,087	$152K
77301		<1%	133	$152K
67113		<1%	266	$149K
84443	Thyroid stimulating hormone (TSH)	<1%	18,338	$146K
76536		<1%	3,037	$144K
74178		<1%	883	$144K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	19,370	$142K
83735		<1%	31,227	$138K
83970		<1%	3,187	$137K
80197		<1%	7,349	$137K
J0490	Injection, belimumab, 10 mg	<1%	160	$136K
0250		<1%	7,954	$134K
0361		<1%	833	$133K
76937		<1%	2,765	$133K
90837	Psychotherapy session, about an hour	<1%	1,471	$133K
G0382	Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	2,174	$133K
94060		<1%	3,160	$132K
99499		<1%	1,178	$131K
86850		<1%	21,696	$130K
96367		<1%	3,880	$128K
73221		<1%	542	$128K
75574		<1%	509	$128K
97165		<1%	2,871	$128K
93623		<1%	40	$125K
81001		<1%	79,176	$121K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	9,580	$119K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,335	$118K
86900		<1%	28,386	$113K
92522		<1%	988	$106K
72157		<1%	268	$105K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	4,040	$105K
J1756	Injection, iron sucrose, 1 mg	<1%	4,166	$105K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	66	$104K
74174		<1%	774	$104K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,479	$101K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	569	$101K
G0383	Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	1,153	$100K
84484		<1%	48,333	$100K
82378		<1%	4,345	$100K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	7,583	$99K
76642		<1%	1,918	$98K
88307		<1%	1,895	$98K
54640		<1%	303	$96K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	7,395	$95K
86901		<1%	25,737	$94K
97802		<1%	637	$94K
95708		<1%	274	$93K
0762		<1%	5,157	$93K
96411		<1%	1,953	$92K
94729		<1%	2,328	$92K
86999		<1%	2,595	$91K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,134	$90K
36415	Collection of venous blood by venipuncture	<1%	31,687	$89K
14040		<1%	794	$88K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	308	$88K
95816		<1%	903	$87K
87077		<1%	21,126	$87K
87088		<1%	27,421	$85K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	4,372	$84K
93017		<1%	1,536	$83K
99217		<1%	2,414	$83K
83690		<1%	38,024	$83K
93451		<1%	77	$80K
87799		<1%	1,502	$79K
J1644	Injection, heparin sodium, per 1000 units	<1%	6,660	$78K
92523		<1%	847	$78K
93308		<1%	2,096	$77K
88342		<1%	2,752	$77K
J9267	Injection, paclitaxel, 1 mg	<1%	4,237	$77K
93225		<1%	1,829	$77K
88185		<1%	352	$77K
76801		<1%	2,722	$77K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	4,864	$76K
J2323	Injection, natalizumab, 1 mg	<1%	154	$74K
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,676	$74K
87070		<1%	9,301	$74K
84100		<1%	24,738	$73K
77066	Tomosynthesis, mammo	<1%	545	$71K
70487		<1%	1,015	$70K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	701	$70K
0761		<1%	1,929	$70K
96523		<1%	875	$69K
77065	Tomosynthesis, mammo	<1%	661	$69K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	12,163	$68K
A9562	Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries	<1%	106	$68K
J9045	Injection, carboplatin, 50 mg	<1%	2,442	$68K
70546		<1%	182	$68K
74160		<1%	317	$67K
96368		<1%	2,606	$67K
85730		<1%	32,591	$65K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	2,543	$65K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	9,142	$65K
94726		<1%	1,749	$65K
87497		<1%	1,175	$63K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	797	$62K
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	1,759	$62K
93656		<1%	26	$62K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	6,200	$61K
82805		<1%	3,686	$60K
73630		<1%	6,149	$60K
87430		<1%	6,588	$59K
83880		<1%	8,814	$59K
72131		<1%	973	$58K
A9270	Non-covered item or service	<1%	42,761	$58K
99224		<1%	826	$58K
78306		<1%	481	$58K
85610		<1%	36,214	$58K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	4,089	$57K
97803		<1%	801	$57K
72146		<1%	235	$56K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	3,718	$55K
73610		<1%	5,222	$54K
73130		<1%	5,677	$54K
78264		<1%	238	$54K
G0381	Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	1,500	$53K
86945		<1%	875	$50K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	344	$50K
93243		<1%	439	$49K
74170		<1%	294	$48K
76942		<1%	742	$47K
75561		<1%	146	$46K
97166		<1%	1,122	$46K
76641		<1%	659	$45K
96402		<1%	1,608	$45K
73564		<1%	4,336	$44K
93880		<1%	442	$43K
74018		<1%	6,309	$43K
83615		<1%	6,182	$43K
93312		<1%	407	$42K
J3480	Injection, potassium chloride, per 2 meq	<1%	4,226	$42K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	1,118	$41K
J9070	Cyclophosphamide, 100 mg	<1%	142	$41K
J2997	Injection, alteplase recombinant, 1 mg	<1%	484	$40K
96377		<1%	1,786	$40K
G0378	Hospital observation service, per hour	<1%	5,133	$39K
C9399	Unclassified drugs or biologicals	<1%	321	$38K
82728		<1%	3,971	$38K
77338		<1%	135	$38K
77062		<1%	203	$37K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	390	$37K
36561		<1%	154	$37K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	4,215	$36K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,451	$35K
84702		<1%	5,535	$35K
86833		<1%	1,066	$35K
73030		<1%	4,250	$35K
73110		<1%	3,599	$34K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,891	$34K
83605		<1%	13,439	$34K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,164	$33K
72100		<1%	2,963	$33K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,888	$33K
86832		<1%	1,087	$33K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,955	$33K
93454		<1%	53	$33K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	11,856	$32K
82330		<1%	4,413	$31K
76776		<1%	739	$31K
76813		<1%	470	$31K
99225		<1%	451	$31K
84439		<1%	4,552	$31K
J2785	Injection, regadenoson, 0.1 mg	<1%	339	$30K
74240		<1%	398	$30K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,096	$30K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	507	$29K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	940	$29K
G0277	Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval	<1%	230	$29K
93246		<1%	1,885	$29K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,722	$28K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,629	$28K
82570		<1%	5,018	$28K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	1,976	$27K
88304		<1%	1,865	$27K
76870		<1%	1,537	$27K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	4,832	$27K
85007		<1%	11,751	$26K
67042		<1%	26	$25K
73700		<1%	313	$25K
0272		<1%	11,954	$24K
73590		<1%	4,090	$24K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,494	$23K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,413	$23K
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	2,102	$23K
84550		<1%	4,601	$23K
90715		<1%	2,466	$23K
90791	Psychiatric diagnostic evaluation	<1%	138	$23K
94618		<1%	940	$22K
72128		<1%	477	$22K
90832	Psychotherapy session, about 30 minutes	<1%	363	$22K
T1024	Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter	<1%	186	$21K
74220		<1%	671	$21K
43762		<1%	530	$21K
73090		<1%	3,895	$21K
96401		<1%	245	$21K
C1769	Guide wire	<1%	1,067	$21K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	10,814	$21K
73080		<1%	2,800	$20K
87536		<1%	398	$20K
87147		<1%	7,401	$20K
73562		<1%	2,269	$20K
10060		<1%	975	$20K
86300		<1%	1,477	$20K
74328		<1%	103	$19K
95813		<1%	235	$19K
87040		<1%	8,082	$19K
30140		<1%	237	$19K
85347		<1%	1,479	$19K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,788	$18K
77470		<1%	162	$18K
86301		<1%	1,037	$18K
78709		<1%	83	$18K
80061	Lipid panel	<1%	2,369	$18K
88184		<1%	361	$18K
83550		<1%	3,090	$18K
86803		<1%	1,379	$17K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	195	$17K
97161		<1%	948	$17K
86304		<1%	918	$17K
J9190	Injection, fluorouracil, 500 mg	<1%	714	$17K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	132	$16K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	28	$16K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	480	$16K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	342	$16K
84132		<1%	6,421	$16K
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	89	$16K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	1,016	$16K
0681		<1%	21	$16K
C1771	Repair device, urinary, incontinence, with sling graft	<1%	12	$15K
73502		<1%	1,252	$15K
87340		<1%	1,921	$15K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	3,143	$15K
30520		<1%	210	$15K
87205		<1%	4,465	$14K
C1874	Stent, coated/covered, with delivery system	<1%	12	$14K
A4913	Miscellaneous dialysis supplies, not otherwise specified	<1%	877	$14K
0459		<1%	1,174	$14K
84156		<1%	3,963	$14K
J9075	Injection, cyclophosphamide, not otherwise specified, 5 mg	<1%	324	$14K
76604		<1%	1,263	$14K
77321		<1%	142	$13K
87186		<1%	2,370	$13K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,153	$13K
72070		<1%	1,137	$13K
77063	Screening digital breast tomosynthesis, bilateral	<1%	416	$13K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	696	$12K
87390		<1%	960	$12K
73552		<1%	2,105	$12K
96376		<1%	2,727	$12K
85018		<1%	6,170	$12K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,332	$12K
77001		<1%	148	$12K
86140		<1%	7,371	$12K
43235		<1%	163	$12K
97116		<1%	2,479	$11K
J1940	Injection, furosemide, up to 20 mg	<1%	2,042	$11K
93505		<1%	31	$11K
87522	Neg quan hep c or qual rna	<1%	233	$11K
73060		<1%	2,349	$11K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	711	$11K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	51	$11K
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	579	$11K
J2720	Injection, protamine sulfate, per 10 mg	<1%	602	$11K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	819	$10K
94010		<1%	551	$10K
36591		<1%	614	$10K
93356		<1%	234	$10K
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	90	$10K
72040		<1%	1,095	$10K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	723	$10K
82810		<1%	765	$9K
82105		<1%	197	$9K
41899	Unlisted procedure, dentoalveolar structures	<1%	209	$9K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,520	$9K
87210		<1%	3,882	$9K
86706		<1%	999	$9K
86702		<1%	990	$9K
30465		<1%	20	$9K
87517		<1%	159	$9K
J2060	Injection, lorazepam, 2 mg	<1%	2,413	$9K
0760		<1%	392	$9K
85379		<1%	2,491	$9K
82550		<1%	5,222	$8K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,219	$8K
87102		<1%	841	$8K
76882		<1%	983	$8K
0270		<1%	8,321	$8K
73140		<1%	591	$8K
82248		<1%	1,393	$8K
82607		<1%	655	$8K
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	503	$8K
75572		<1%	53	$8K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	56	$7K
J2800	Injection, methocarbamol, up to 10 ml	<1%	1,186	$7K
88313		<1%	193	$7K
89051		<1%	1,065	$7K
84520		<1%	2,776	$7K
74022		<1%	1,338	$7K
82784		<1%	984	$7K
J9206	Injection, irinotecan, 20 mg	<1%	289	$7K
J1171	Injection, hydromorphone, 0.1 mg	<1%	328	$7K
72170		<1%	1,730	$7K
87075		<1%	568	$7K
86701		<1%	990	$7K
82435		<1%	3,575	$6K
93242		<1%	439	$6K
84145		<1%	1,980	$6K
85652		<1%	6,392	$6K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	753	$6K
71270		<1%	161	$6K
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	<1%	119	$6K
84295		<1%	3,695	$6K
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	714	$6K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	174	$6K
36430		<1%	136	$6K
78451		<1%	15	$6K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	326	$6K
76000		<1%	24	$6K
88331		<1%	232	$5K
82247		<1%	732	$5K
92610		<1%	274	$5K
88350		<1%	13	$5K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	508	$5K
0259		<1%	10,143	$5K
A4315	Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone	<1%	92	$5K
86704		<1%	626	$5K
77075		<1%	491	$5K
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	61	$5K
82274		<1%	1,141	$5K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	100	$5K
62270		<1%	120	$5K
70480		<1%	42	$5K
A6258	Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	<1%	420	$5K
92526		<1%	75	$5K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,160	$5K
93321		<1%	207	$5K
97162		<1%	255	$5K
12001		<1%	661	$4K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,556	$4K
70481		<1%	44	$4K
86593		<1%	1,479	$4K
90839		<1%	941	$4K
J8540	Dexamethasone, oral, 0.25 mg	<1%	348	$4K
73100		<1%	773	$4K
82553		<1%	2,318	$4K
73560		<1%	569	$4K
A4217	Sterile water/saline, 500 ml	<1%	969	$4K
86334		<1%	186	$4K
82746		<1%	319	$4K
82150		<1%	1,567	$4K
58571		<1%	13	$4K
61782		<1%	41	$4K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	368	$4K
J3489	Injection, zoledronic acid, 1 mg	<1%	139	$4K
82310		<1%	434	$4K
0296T		<1%	404	$4K
L2112	Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment	<1%	25	$4K
73720		<1%	12	$3K
84153		<1%	300	$3K
87184		<1%	1,234	$3K
78018		<1%	14	$3K
83521		<1%	302	$3K
A9573	Injection, gadopiclenol, 1 ml	<1%	150	$3K
31267		<1%	18	$3K
86480		<1%	185	$3K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	283	$3K
86902		<1%	55	$3K
83520		<1%	259	$3K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	19	$3K
85046		<1%	852	$3K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	672	$3K
10005		<1%	58	$3K
82108		<1%	331	$3K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	78	$3K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	2,070	$3K
82010		<1%	1,355	$3K
93662		<1%	24	$3K
73501		<1%	537	$2K
64642		<1%	38	$2K
73070		<1%	807	$2K
91010		<1%	56	$2K
54360		<1%	24	$2K
J1630	Injection, haloperidol, up to 5 mg	<1%	1,372	$2K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	957	$2K
93613		<1%	27	$2K
J0736	Injection, clindamycin phosphate, 300 mg	<1%	168	$2K
86769		<1%	51	$2K
J2252	Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg	<1%	116	$2K
51702		<1%	312	$2K
12011		<1%	355	$2K
80299		<1%	243	$2K
85384		<1%	317	$2K
J1836	Injection, metronidazole, 10 mg	<1%	161	$2K
51701		<1%	142	$2K
58661		<1%	13	$2K
64643		<1%	85	$2K
J9171	Injection, docetaxel, 1 mg	<1%	61	$2K
88300		<1%	450	$2K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	59	$2K
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	607	$2K
86308		<1%	852	$2K
86762		<1%	135	$2K
84165		<1%	181	$2K
80143		<1%	1,886	$2K
43760		<1%	63	$2K
70355		<1%	312	$2K
57288		<1%	24	$2K
J1953	Injection, levetiracetam, 10 mg	<1%	187	$1K
A0429	Emergency ambulance ride, basic life support	<1%	96	$1K
77080		<1%	40	$1K
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	196	$1K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	599	$1K
86592		<1%	477	$1K
70250		<1%	156	$1K
74019		<1%	564	$1K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	135	$1K
87116		<1%	126	$1K
71100		<1%	54	$1K
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	166	$1K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	15	$1K
93923		<1%	13	$1K
49500		<1%	17	$1K
88112		<1%	26	$1K
73521		<1%	84	$1K
86870		<1%	42	$1K
G0384	Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	13	$1K
86235		<1%	77	$1K
82140		<1%	377	$1K
90686		<1%	105	$1K
0258		<1%	1,675	$994.47
74230		<1%	26	$993.50
62328		<1%	12	$983.12
50200		<1%	27	$943.39
0271		<1%	1,673	$935.63
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	353	$928.93
88173		<1%	38	$926.34
97003		<1%	23	$906.62
93924		<1%	12	$825.71
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	46	$818.28
20680		<1%	15	$812.00
83020		<1%	74	$807.04
93319		<1%	15	$781.14
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	46	$775.94
87206		<1%	162	$771.24
73200		<1%	15	$771.01
71020		<1%	168	$724.45
97018		<1%	303	$704.39
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	35	$689.15
84460		<1%	358	$653.72
88360		<1%	28	$647.72
84450		<1%	360	$639.62
S0164	Injection, pantoprazole sodium, 40 mg	<1%	106	$632.49
99195		<1%	32	$630.35
82977		<1%	45	$624.51
80074		<1%	12	$536.08
93797		<1%	24	$535.04
84403		<1%	28	$513.13
82945		<1%	282	$508.29
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	175	$502.12
88311		<1%	193	$501.16
80076		<1%	130	$498.05
84157		<1%	294	$484.36
86780		<1%	83	$406.46
36224		<1%	13	$403.13
82525		<1%	29	$309.19
84478		<1%	72	$288.81
84630		<1%	33	$279.91
84255		<1%	16	$256.20
64644		<1%	21	$240.00
86318		<1%	105	$230.01
94760		<1%	27	$228.27
86787		<1%	24	$227.58
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	1,142	$225.53
94770		<1%	37	$224.37
97026		<1%	140	$223.16
G0380	Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	13	$222.80
88346		<1%	12	$222.00
88302		<1%	27	$208.57
87106		<1%	27	$201.00
0042T		<1%	88	$197.85
J1120	Injection, acetazolamide sodium, up to 500 mg	<1%	12	$193.19
12002		<1%	126	$186.80
G1010	Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program	<1%	1,807	$183.29
82365		<1%	14	$182.93
86735		<1%	14	$176.48
86765		<1%	14	$174.30
86665		<1%	27	$154.80
73620		<1%	13	$154.38
87045		<1%	42	$150.34
J2470	Injection, pantoprazole sodium, 40 mg	<1%	39	$148.67
73660		<1%	14	$130.80
J2359	Injection, olanzapine, 0.5 mg	<1%	37	$123.78
J0694	Injection, cefoxitin sodium, 1 gm	<1%	13	$123.41
86777		<1%	12	$121.62
86644		<1%	12	$117.72
70360		<1%	40	$108.35
74000		<1%	52	$108.03
73000		<1%	33	$98.17
99213	Doctor's office visit, returning patient (routine)	<1%	15	$92.86
87427		<1%	27	$92.70
81003		<1%	337	$92.14
31720		<1%	114	$85.12
82043		<1%	12	$75.42
71010		<1%	28	$74.45
36600		<1%	14	$73.69
0621		<1%	16	$71.75
86664		<1%	13	$68.22
85651		<1%	157	$67.31
87324		<1%	12	$66.16
87449		<1%	12	$66.16
86663		<1%	13	$60.31
0100U		<1%	91	$55.12
80164		<1%	57	$43.27
87185		<1%	28	$37.99
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	16	$34.49
76010		<1%	14	$25.40
A6453	Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard	<1%	192	$2.62
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	101	$0.01
0637		0%	1,070	$0.00
C1758	Catheter, ureteral	0%	30	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	14	$0.00
77076		0%	12	$0.00
94664		0%	17	$0.00
85396		0%	12	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	20	$0.00
A6449	Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard	0%	55	$0.00
80320		0%	78	$0.00
0636		0%	37	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	20	$0.00
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	0%	12	$0.00
G0008	Administration of influenza virus vaccine	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHILLARD, ANTHONY (CEO)